Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd20-02-2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services LtdDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt LtdFortis Healthcare Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Fortis Healthcare Ltd with respect to news appearing in www.timesofindia.com - February 19, 2018 titled "Fortis, Religare face serious fraud probe; Sebi orders inquiry"Fortis Healthcare Ltd response is enclosed.Clarification sought from Fortis Healthcare Ltd
The Exchange has sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.timesofindia.com - February 19, 2018 titled "Fortis, Religare face serious fraud probe; Sebi orders inquiry".The reply is awaited.SFIO to probe Fortis, Religare for alleged 'loan' to Singh brothers
The corporate affairs ministry has been looking into the affairs of Fortis Healthcare and Religare Enterprises after recent reports that financial irregularities have emerged at the two companiesSebi to probe Fortis deals, asks company to provide information by Feb 26
Replying to notices, Fortis Healthcare said its wholly-owned arm Fortis Hospitals had deployed funds to the tune of Rs 4.73 billion as secured short-term investments to group firms of its promotersAnnouncement under Regulation 30 (LODR)-Updates
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received a communication from Securities and Exchange Board of India (SEBI) vide Ref. No. SEBI/HO/IVD/ID2/PS/CMR/FHL/5288/1/2018 dated February 16, 2018, confirming that an investigation has been instituted by SEBI in the matter of FORTIS HEALTHCARE LIMITED. Vide aforesaid letter, SEBI has asked to furnish...COMING UP: Mark your calendars
Fortis Healthcare is scheduled to come out with its results for two quarters after its board meeting was postponed from February 13 to 28. Last fortnight saw a flurry of activity involvingAnnouncement under Regulation 30 (LODR)-Updates
This is in continuation to our letter(s) dated 11.08.17 and 31.08.17, whereby the Company had informed that, in the matter relating to M/s Daiichi Sankyo Company Limited v/s Oscar Investments Limited & Others, the Hon'ble Supreme Court of India had directed to maintain status quo with regards to the holding of Fortis Healthcare Holding Private Limited (FHHPL), a Promoter Group Entity, in the Company for both the encumbered and unencumbered shares....Announcement under Regulation 30 (LODR)-Credit Rating
Dear Sir(s), With reference to the provisions of the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, it is hereby informed that there has been a change in the credit ratings by 'CARE Ratings' of the Company and one of its subsidiaries- M/s. Escorts Heart Institute and Research Centre Limited....